HURA
TuHURA Biosciences, Inc./NV
Key Financials
Revenue
$0
NaN%
Operating Income
$-65008
N/A
Net Income
$-30051977
↓ 38.6%
Total Assets
$27.4M
↑ 37.0%
Shareholders' Equity
$20.9M
↑ 43.4%
Total Liabilities
$6.4M
↑ 19.5%
EPS (Diluted)
$-0.63
↑ 47.9%
Cash & Equivalents
$3.6M
↓ 71.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/24/2026 | View on SEC |
| 8-K | 9/17/2026 | View on SEC |
| 8-K/A | 9/17/2026 | View on SEC |
| 8-K | 9/16/2026 | View on SEC |
| 8-K | 9/4/2026 | View on SEC |
| SCHEDULE 13D/A | 8/28/2026 | View on SEC |
| 8-K | 8/21/2026 | View on SEC |
| 8-K | 8/19/2026 | View on SEC |
| 10-Q | 8/14/2026 | View on SEC |
| 8-K | 8/14/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | HURA |
| Company Name | TuHURA Biosciences, Inc./NV |
| CIK | 1498382 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 813-875-6600 |